Schiepers et al. (2023) “Molecular fate-mapping of serum antibody responses to repeat immunization” Nature.
DOI: 10.1038/s41586-023-05715-3
News & Publications
Arevalo et al. (2022) “A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes” Science.
DOI: 10.1126/science.abm0271
Gorsuch et al. (2022) “Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo” Molecular Therapy.
DOI: 10.1016/j.ymthe.2022.05.013
Pardi et al. (2022) “Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses” Nature Communications.
DOI: 10.1038/s41467-022-32149-8
Mu et al. (2022) “mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice” Cell Reports.
DOI: 10.1016/j.celrep.2022.110514
Rurik et al. (2022) “CAR T cells produced in vivo to treat cardiac injury” Science.
DOI: 10.1126/science.abm0594
Mallory et al. (2021) “Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice” NPJ Vaccines.
DOI: 10.1038/s41541-021-00345-0
Musunuru et al. (2021) “In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates” Nature.
DOI:10.1038/s41586-021-03534-y
Rothgangl et al. (2021) “In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels” Nature Biotechnology.
DOI:10.1038/s41587-021-00933-4
Rizvi et al. (2021) “Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA” Nature Communications.
DOI:10.1038/s41467-021-20903-3
Villiger et al. (2021) “In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA” Nature Biomedical Engineering.
DOI:10.1038/s41551-020-00671-z
Weissman et al. (2021) “D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization” Cell Host & Microbe.
DOI:10.1016/j.chom.2020.11.012